|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 383.25 USD | -6.07% |
|
-6.07% | -12.16% |
| 21/07 | Virbac: Impressive execution in Q2; we smell a guidance upgrade in Q3 |  |
| 21/07 | Despite the escalation in the Middle East, European stocks stay the course |  |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- VIRP Stock
- VRBCF Stock
- Consensus Virbac
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
